Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × Fluorescein × Clear all

NCT01614184 2013-07-10

Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer

Phase 1/2 Withdrawn

Breast Neoplasms